Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 21.12M
March 31, 2026 1.141M
December 31, 2025 0.645M
September 30, 2025 151.65M
June 30, 2025 151.40M
March 31, 2025 152.02M
December 31, 2024 153.77M
September 30, 2024 151.96M
June 30, 2024 154.42M
March 31, 2024 154.34M
December 31, 2023 157.33M
September 30, 2023 164.33M
June 30, 2023 163.28M
March 31, 2023 157.33M
Date Value
December 31, 2022 153.22M
September 30, 2022 148.22M
June 30, 2022 144.32M
March 31, 2022 141.57M
December 31, 2021 141.32M
September 30, 2021 141.93M
June 30, 2021 140.79M
March 31, 2021 81.06M
December 31, 2020 77.98M
September 30, 2020 73.38M
June 30, 2020 74.06M
March 31, 2020 77.76M
December 31, 2019 53.77M
September 30, 2019 52.30M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. 3.65M
Cue Biopharma, Inc. 28.40M
Yarrow Bioscience, Inc. 1.542M
Faeth Therapeutics, Inc. 11.08M
Immuneering Corp. 13.88M

Total Liabilities (Quarterly) Related Metrics